share_log

Investors Aren't Buying Focused Photonics (Hangzhou), Inc.'s (SZSE:300203) Revenues

Simply Wall St ·  Dec 17, 2023 19:55

You may think that with a price-to-sales (or "P/S") ratio of 2.2x Focused Photonics (Hangzhou), Inc. (SZSE:300203) is a stock worth checking out, seeing as almost half of all the Commercial Services companies in China have P/S ratios greater than 3.5x and even P/S higher than 6x aren't out of the ordinary. However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.

Check out our latest analysis for Focused Photonics (Hangzhou)

ps-multiple-vs-industry
SZSE:300203 Price to Sales Ratio vs Industry December 18th 2023

What Does Focused Photonics (Hangzhou)'s Recent Performance Look Like?

While the industry has experienced revenue growth lately, Focused Photonics (Hangzhou)'s revenue has gone into reverse gear, which is not great. Perhaps the P/S remains low as investors think the prospects of strong revenue growth aren't on the horizon. If you still like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's out of favour.

If you'd like to see what analysts are forecasting going forward, you should check out our free report on Focused Photonics (Hangzhou).

How Is Focused Photonics (Hangzhou)'s Revenue Growth Trending?

The only time you'd be truly comfortable seeing a P/S as low as Focused Photonics (Hangzhou)'s is when the company's growth is on track to lag the industry.

In reviewing the last year of financials, we were disheartened to see the company's revenues fell to the tune of 13%. As a result, revenue from three years ago have also fallen 9.1% overall. Therefore, it's fair to say the revenue growth recently has been undesirable for the company.

Shifting to the future, estimates from the lone analyst covering the company suggest revenue should grow by 29% over the next year. That's shaping up to be materially lower than the 34% growth forecast for the broader industry.

With this in consideration, its clear as to why Focused Photonics (Hangzhou)'s P/S is falling short industry peers. Apparently many shareholders weren't comfortable holding on while the company is potentially eyeing a less prosperous future.

What Does Focused Photonics (Hangzhou)'s P/S Mean For Investors?

It's argued the price-to-sales ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

As expected, our analysis of Focused Photonics (Hangzhou)'s analyst forecasts confirms that the company's underwhelming revenue outlook is a major contributor to its low P/S. At this stage investors feel the potential for an improvement in revenue isn't great enough to justify a higher P/S ratio. Unless these conditions improve, they will continue to form a barrier for the share price around these levels.

You need to take note of risks, for example - Focused Photonics (Hangzhou) has 2 warning signs (and 1 which doesn't sit too well with us) we think you should know about.

If companies with solid past earnings growth is up your alley, you may wish to see this free collection of other companies with strong earnings growth and low P/E ratios.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment